Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WaveCrest Group Enterprises was a specialized contract research organization (CRO) that provided comprehensive clinical trial management services to the pharmaceutical and biotechnology industries. The company focused on patient recruitment, site selection, and clinical monitoring for Phase I through Phase IV clinical trials. WaveCrest was particularly recognized for its expertise in optimizing patient enrollment strategies and improving retention rates in complex clinical programs. In 2006, the company was acquired by Acurian, a leading provider of clinical trial enrollment solutions, to enhance its global recruitment capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WaveCrest Group Enterprises.